Latest filing published 06 Mar 2026 for Orthofix Medical Inc., €12k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Max Reinhardt across 2 companies, led by Pacira BioSciences, Inc. and Orthofix Medical Inc. Over a trading history stretching from 4 June 2021 to 4 March 2026, the count stands at 12 filings.
No open-market purchase appears, only 7 sales worth €393k. Other entries cover 3 share grants and 2 option exercises. 2026 to date brings no purchases and 1 sale.
The record was last updated on 6 March 2026 with an open-market sale (€12k) in Orthofix Medical Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations